Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesicles.

Autor: Kim HJ; Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA., Rames MJ; Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA., Goncalves F; Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA., Kirschbaum CW; Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Roskams-Hieter B; Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Spiliotopoulos E; Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Briand J; Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Doe A; Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Estabrook J; Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Computational Biology Program, Oregon Health and Science University, Portland, OR, USA., Wagner JT; Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Molecular Genomics Laboratory, Providence Health and Services, Portland, OR, USA., Demir E; Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Computational Biology Program, Oregon Health and Science University, Portland, OR, USA.; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA., Mills G; Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Ngo TTM; Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. ngth@ohsu.edu.; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA. ngth@ohsu.edu.; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA. ngth@ohsu.edu.; Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. ngth@ohsu.edu.

Publikováno v: Communications biology [Commun Biol] 2023 Aug 29; Vol. 6 (1), pp. 885. Date of Electronic Publication: 2023 Aug 29.

SMARCA4 biology in alveolar rhabdomyosarcoma.

Autor: Bharathy N; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA.; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Cleary MM; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA., Kim JA; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA., Nagamori K; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA., Crawford KA; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA., Wang E; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 11724, USA., Saha D; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA.; CSIR-CCMB, Uppal Road, Hyderabad, 500007, India., Settelmeyer TP; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA., Purohit R; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA., Skopelitis D; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 11724, USA., Chang K; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 11724, USA., Doran JA; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA., Kirschbaum CW; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA., Bharathy S; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA., Crews DW; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA., Randolph ME; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA., Karnezis AN; University of California C Davis Medical Center, Sacramento, CA, 95817, USA.; British Columbia Cancer Research Center, Vancouver, BC, V5Z 1L3, Canada., Hudson-Price L; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA., Dhawan J; CSIR-CCMB, Uppal Road, Hyderabad, 500007, India., Michalek JE; Department of Epidemiology and Biostatistics, University of Texas Health Science Center, San Antonio, TX, 78229, USA., Ciulli A; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK. a.ciulli@dundee.ac.uk., Vakoc CR; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 11724, USA., Keller C; Children's Cancer Therapy Development Institute, Beaverton, OR, 97005, USA. charles@cc-tdi.org.

Publikováno v: Oncogene [Oncogene] 2022 Mar; Vol. 41 (11), pp. 1647-1656. Date of Electronic Publication: 2022 Jan 29.